Drugs / STN1010904
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05376176 | May 2022 → May 2025 | Fuchs' endothelial dystrophy | Santen Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | STN1010904 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05376176 ↗ |